P53 suppresses expression of the 14-3-3gamma oncogene

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Radhakrishnan, Vijayababu M ^a,b   Putnam, Charles W ^a   Qi, Wenqing ^a,c   Martinez, Jesse D ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b Department of Pediatrics   (United States)

^c Department of Surgery ^*  (United States)

Author keywords

14 3 3; Gene copy; Lung cancer; P53 mutations; Transcription regulation

Indexed keywords

MESSENGER RNA; PROTEIN P53; PROTEIN 14 3 3;

14 3 3 GAMMA GENE; ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE DELETION; GENE DOSAGE; GENE OVEREXPRESSION; GENE REPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MOLECULAR INTERACTION; ONCOGENE; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; BINDING SITE; CELL STRAIN HCT116; COLORECTAL TUMOR; CONSENSUS SEQUENCE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; MUTATION; NUCLEOTIDE SEQUENCE; TUMOR CELL LINE;

14-3-3 PROTEINS; BASE SEQUENCE; BINDING SITES; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; CONSENSUS SEQUENCE; GENE AMPLIFICATION; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; LUNG NEOPLASMS; MUTATION; ONCOGENES; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53;

EID: 80052037870     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-378     Document Type: Article

References (25)

1. Muslin AJ, Tanner JW, Allen PM, Shaw AS. Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 1996, 84(6):889-97. 10.1016/S0092-8674(00)81067-3, 8601312.
2. Fu H, Subramanian RR, Masters SC. 14-3-3 proteins: structure, function, and regulation. Annual review of pharmacology and toxicology 2000, 40:617-47. 10.1146/annurev.pharmtox.40.1.617, 10836149.
3. Hermeking H, Lengauer C, Polyak K, et al. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Molecular cell 1997, 1(1):3-11. 10.1016/S1097-2765(00)80002-7, 9659898.
4. Porter GW, Khuri FR, Fu H. Dynamic 14-3-3/client protein interactions integrate survival and apoptotic pathways. Seminars in cancer biology 2006, 16(3):193-202. 10.1016/j.semcancer.2006.03.003, 16697216.
5. Thorson JA, Yu LW, Hsu AL, et al. 14-3-3 proteins are required for maintenance of Raf-1 phosphorylation and kinase activity. Molecular and cellular biology 1998, 18(9):5229-38. 109108, 9710607.
6. Ichimura T, Isobe T, Okuyama T, Yamauchi T, Fujisawa H. Brain 14-3-3 protein is an activator protein that activates tryptophan 5-monooxygenase and tyrosine 3-monooxygenase in the presence of Ca2+, calmodulin-dependent protein kinase II. FEBS letters 1987, 219(1):79-82. 10.1016/0014-5793(87)81194-8, 2885229.
7. Berg D, Holzmann C, Riess O. 14-3-3 proteins in the nervous system. Nature reviews 2003, 4(9):752-62. 10.1038/nrn1197, 12951567.
8. Qi W, Liu X, Qiao D, Martinez JD. Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues. International journal of cancer 2005, 113(3):359-63.
9. Cheng L, Pan CX, Zhang JT, et al. Loss of 14-3-3sigma in prostate cancer and its precursors. Clin Cancer Res 2004, 10(9):3064-8. 10.1158/1078-0432.CCR-03-0652, 15131044.
10. Umbricht CB, Evron E, Gabrielson E, Ferguson A, Marks J, Sukumar S. Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer. Oncogene 2001, 20(26):3348-53. 10.1038/sj.onc.1204438, 11423985.
11. Matta A, Bahadur S, Duggal R, Gupta SD, Ralhan R. Over-expression of 14-3-3zeta is an early event in oral cancer. BMC cancer 2007, 7:169. 10.1186/1471-2407-7-169, 2082039, 17764575.
12. Akahira J, Sugihashi Y, Suzuki T, et al. Decreased expression of 14-3-3 sigma is associated with advanced disease in human epithelial ovarian cancer: its correlation with aberrant DNA methylation. Clin Cancer Res 2004, 10(8):2687-93. 10.1158/1078-0432.CCR-03-0510, 15102672.
13. Guweidhi A, Kleeff J, Giese N, et al. Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis. Carcinogenesis 2004, 25(9):1575-85. 10.1093/carcin/bgh159, 15073049.
14. Okada T, Masuda N, Fukai Y, et al. Immunohistochemical expression of 14-3-3 sigma protein in intraductal papillary-mucinous tumor and invasive ductal carcinoma of the pancreas. Anticancer research 2006, 26(4B):3105-10.
15. Chan TA, Hermeking H, Lengauer C, Kinzler KW, Vogelstein B. 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature 1999, 401(6753):616-20. 10.1038/44188, 10524633.
16. Urano T, Saito T, Tsukui T, et al. Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth. Nature 2002, 417(6891):871-5. 10.1038/nature00826, 12075357.
17. Dellambra E, Golisano O, Bondanza S, et al. Downregulation of 14-3-3sigma prevents clonal evolution and leads to immortalization of primary human keratinocytes. The Journal of cell biology 2000, 149(5):1117-30. 10.1083/jcb.149.5.1117, 2174818, 10831615.
18. Jin YH, Kim YJ, Kim DW, et al. Sirt2 interacts with 14-3-3 beta/gamma and down-regulates the activity of p53. Biochemical and biophysical research communications 2008, 368(3):690-5. 10.1016/j.bbrc.2008.01.114, 18249187.
19. Qi W, Liu X, Chen W, Li Q, Martinez JD. Overexpression of 14-3-3gamma causes polyploidization in H322 lung cancer cells. Molecular carcinogenesis 2007, 46(10):847-56. 10.1002/mc.20314, 17394238.
20. Carney DN. Oncogenes and genetic abnormalities in lung cancer. Chest 1989, 96(1 Suppl):25S-7S. 10.1378/chest.96.1_Supplement.25S, 2544354.
21. Massion PP, Kuo WL, Stokoe D, et al. Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: implications of the phosphatidylinositol 3-kinase pathway. Cancer research 2002, 62(13):3636-40.
22. Kuo MH, Allis CD. In vivo cross-linking and immunoprecipitation for studying dynamic Protein:DNA associations in a chromatin environment. Methods (San Diego, Calif 1999, 19(3):425-33.
23. Radhakrishnan VM, Martinez JD. 14-3-3gamma induces oncogenic transformation by stimulating MAP kinase and PI3K signaling. PloS one 5(7):e11433.
24. Fu L, Benchimol S. Participation of the human p53 3'UTR in translational repression and activation following gamma-irradiation. The EMBO journal 1997, 16(13):4117-25. 10.1093/emboj/16.13.4117, 1170034, 9233820.
25. Riley T, Sontag E, Chen P, Levine A. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 2008, 9(5):402-12. 10.1038/nrm2395, 18431400.